Endocrine evaluation after an intra-articular therapeutic dosage of dexamethasone in horses

J Vet Pharmacol Ther. 2013 Dec;36(6):542-9. doi: 10.1111/jvp.12046. Epub 2013 Apr 1.

Abstract

This study investigated whether a single intra-articular administration (IA) of dexamethasone (DEX) in horses at therapeutic dosage could exert a systemic effect by influencing the hypothalamic-pituitary-adrenal axis activity as a consequence of (limited) absorption and systemic distribution. The results indicated that DEX was detectable in urine collected 12-48 h after IA administration and that injection was accompanied by a reduced urine excretion of cortisol, 6β-hydroxycortisol (6βOHF) and two other metabolites of cortisol lasting up to 48 h post-DEX administration. The systemic effects in horses treated with DEX by IA route are similar to those that typically occur with short-term treatment including the reduction in urinary cortisol concentration.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology*
  • Chromatography, Liquid
  • Dexamethasone / administration & dosage
  • Dexamethasone / pharmacology*
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Horses / blood*
  • Horses / urine*
  • Hydrocortisone / analogs & derivatives
  • Hydrocortisone / blood
  • Hydrocortisone / urine
  • Injections, Intra-Articular
  • Male
  • Radioimmunoassay / veterinary
  • Tandem Mass Spectrometry

Substances

  • Anti-Inflammatory Agents
  • 6 beta-hydroxycortisol
  • Dexamethasone
  • Hydrocortisone